Aimmune Therapeutics
Biotechnology Research • 
Brisbane, California, United States • 51-100 Employees
Company overview
| Headquarters | 8000 Marina Boulevard,, Suite 300, Brisbane, CA 94005-1884, US |
| Phone number | +16506145220 |
| Website | |
| SIC | 873 |
| Keywords | Drug Development, Food Allergies, Desensitization, Oral Immunotherapy |
| Founded | 2011 |
| Employees | 51-100 |
| Socials |
Key Contacts at Aimmune Therapeutics
Bethany Goodrich
Associate Director, Regulatory Advertising & Promotion
Brett Mccabe
Director, Strategic Accounts
Michael Barco
Sr. Director Of Sales West Region
Alexei Kissell
Associate Director Of Global Commercial Supply Chain
Sridhar Karattur Senniappan
Associate Director Of Information Technology
Michele Jara
Senior Director, Risk Management And Epidemiology
Edward Andrew
Associate Director It & Facilities Europe
Alisa Osako
Quality Control Associate Director
Teresa Ha
Associate Director, Quality Systems
Amy Johnson
Director Product Regulatory Affairs
Aimmune Therapeutics Email Formats
Aimmune Therapeutics uses 2 email formats. The most common is {last name}{last name} (e.g., doedoe@aimmune.com), used 80% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name}{last name} | doedoe@aimmune.com | 80% |
{first initial}{last name} | jdoe@aimmune.com | 20% |
About Aimmune Therapeutics
Aimmune Therapeutics, Inc., a Nestlé Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies. With a mission to improve the lives of people with food allergies, Aimmune is developing and commercializing oral treatments for potentially life-threatening food allergies. The Company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to provide meaningful levels of protection against allergic reactions resulting from accidental exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune has one FDA-approved medicine for peanut allergy and other investigational therapies in development to treat other food allergies. Aimmune is located in Brisbane, California - the heart of San Francisco’s biotechnology hub - with additional offices in Durham, North Carolina; the Paddington area of London, England; Dublin, Ireland; and Munich, Germany. **The information on Aimmune’s LinkedIn channel – including any product information - is intended for U.S. residents only and is governed by applicable U.S. laws and regulations. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
Aimmune Therapeutics revenue & valuation
| Annual revenue | $14,500,000 |
| Revenue per employee | $177,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $46,400,000 |
| Total funding | $200,000,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Aimmune Therapeutics has 39 employees across 9 departments.
Departments
Number of employees
Funding Data
Explore Aimmune Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Aimmune Therapeutics Tech Stack
Discover the technologies and tools that power Aimmune Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
JavaScript libraries
Tag managers
Hosting
Webmail
Programming languages
Security
CMS
JavaScript libraries
UI frameworks
Analytics
Korea, Republic of
Norway
Ireland
Frequently asked questions
4.8
40,000 users
